Press Releases
Washington, D.C. –Congressman Andy Harris M.D. (MD-01) released the following statement after voting in favor of H.R. 7521, a bill that protects the national security of the United States from threats posed by foreign adversary-controlled applications, like TikTok.
WASHINGTON, D.C.—Today, Representatives Earl Blumenauer (D-OR) and Andy Harris, M.D.
Washington, D.C. – Congressman Andy Harris M.D. (MD-01), Chairman of the House Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies released the following statement in response to the Senate’s passage of language, included at his insistence, to contain the invasive blue catfish species in the Chesapeake Bay.
Washington, D.C. – Congressman Andy Harris (MD-01) is pleased to announce that the 2024 Congressional Art Competition is now open for submissions. The competition recognizes talented high school artists from around the country and is supported by the U.S. House of Representatives. All high school students in Maryland’s First Congressional District are encouraged to apply.
Washington, D.C: Congressman Andy Harris, M.D. (MD-01), will hold two telephone town halls this week reaching out to more than 100,000 constituents. On Tuesday, March 5th, Congressman Harris will dial out to constituents on the Upper Shore of the District. Then on Thursday, March 7th, Congressman Harris will dial out to constituents living in the Mid-and-Lower Shore.
Washington, DC – To mark two years since the start of Russia’s unprovoked and illegal invasion of Ukraine the bipartisan Co-Chairs of the Congressional Ukraine Caucus Congresswoman Marcy Kaptur (OH-09), Congressman Brian Fitzpatrick (PA-01), Congressman Mike Quigley (IL-05), and Congressman Andy Harris (MD-01) have introduced H.Res.
Washington, D.C. – Today, Congressman Andy Harris, M.D. (R-MD-01) joined fellow Maryland Congressman Glenn Ivey (D-MD-
Washington, D.C. – On December 19, 2023, the Drug Enforcement Administration (DEA) informed members of Congress that it is now conducting its official review of the Department of Health and Human Services’ (HHS) recommendation to reschedule marijuana from a Schedule I to Schedule III drug under the Controlled Substances Act (CSA).
ICYMI: Congressman Harris Pens Op-Ed On The Need For Congress To Address SNAP’s Contribution To Poor Health |